Hyperosmolar hyperglycemic state secondary prevention: Difference between revisions
No edit summary |
No edit summary |
||
Line 14: | Line 14: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Medicine]] | |||
[[Category:Endocrinology]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Emergency medicine]] |
Latest revision as of 15:17, 17 October 2017
Hyperosmolar hyperglycemic state Microchapters |
Differentiating Hyperosmolar hyperglycemic state from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Hyperosmolar hyperglycemic state secondary prevention On the Web |
American Roentgen Ray Society Images of Hyperosmolar hyperglycemic state secondary prevention |
FDA on Hyperosmolar hyperglycemic state secondary prevention |
CDC on Hyperosmolar hyperglycemic state secondary prevention |
Hyperosmolar hyperglycemic state secondary prevention in the news |
Blogs on Hyperosmolar hyperglycemic state secondary prevention |
Risk calculators and risk factors for Hyperosmolar hyperglycemic state secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Husnain Shaukat, M.D [2]
Overview
Secondary prevention of hyperosmolar hyperglycemic state (HHS) is similar to primary prevention.
Secondary Prevention
- Secondary prevention of hyperosmolar hyperglycemic state (HHS) is similar to primary prevention.